A citation-based method for searching scientific literature

Xiaotian Yuan, Cheng Liu, Kun Wang, Li Liu, Tiantian Liu, Nan Ge, Feng Kong, Liu Yang, Magnus Björkholm, Yidong Fan, Shengtian Zhao, Dawei Xu. Oncotarget 2016
Times Cited: 13







List of co-cited articles
191 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
46

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
46

TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer.
Kun Wang, Tiantian Liu, Cheng Liu, Yan Meng, Xiaotian Yuan, Li Liu, Nan Ge, Jikai Liu, Chang Wang, Hongbo Ren,[...]. Oncologist 2015
22
38

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella,[...]. Proc Natl Acad Sci U S A 2013
871
38

Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.
Yves Allory, Willemien Beukers, Ana Sagrera, Marta Flández, Miriam Marqués, Mirari Márquez, Kirstin A van der Keur, Lars Dyrskjot, Irene Lurkin, Marcel Vermeij,[...]. Eur Urol 2014
158
38

TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR.
Kun Wang, Tiantian Liu, Nan Ge, Li Liu, Xiaotian Yuan, Jikai Liu, Feng Kong, Chang Wang, Hongbo Ren, Keqiang Yan,[...]. Oncotarget 2014
41
38

The association between the TERT rs2736100 AC genotype and reduced risk of upper tract urothelial carcinomas in a Han Chinese population.
Xiaotian Yuan, Yan Meng, Ping Li, Nan Ge, Feng Kong, Liu Yang, Magnus Björkholm, Shengtian Zhao, Dawei Xu. Oncotarget 2016
14
38


TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas.
Kun Wang, Tiantian Liu, Li Liu, Jikai Liu, Cheng Liu, Chang Wang, Nan Ge, Hongbo Ren, Keqiang Yan, Sanyuan Hu,[...]. Oncotarget 2014
49
38

Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
535
30

TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Na Wang, Tiantian Liu, Anastasios Sofiadis, C Christofer Juhlin, Jan Zedenius, Anders Höög, Catharina Larsson, Dawei Xu. Cancer 2014
74
30

Telomerase reverse transcriptase promoter mutations in glandular lesions of the urinary bladder.
Eric Vail, Xiaoyong Zheng, Ming Zhou, Ximing Yang, John T Fallon, Jonathan I Epstein, Minghao Zhong. Ann Diagn Pathol 2015
24
30

Telomerase as a "stemness" enzyme.
Feng Kong, ChengYun Zheng, DaWei Xu. Sci China Life Sci 2014
33
30

TERT promoter mutation in resectable hepatocellular carcinomas: a strong association with hepatitis C infection and absence of hepatitis B infection.
Yu-Ling Chen, Yung-Ming Jeng, Chih-Ning Chang, Hsin-Jung Lee, Hey-Chi Hsu, Po-Lin Lai, Ray-Hwang Yuan. Int J Surg 2014
43
30

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
T Liu, N Wang, J Cao, A Sofiadis, A Dinets, J Zedenius, C Larsson, D Xu. Oncogene 2014
160
30

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.
Jean Charles Nault, Maxime Mallet, Camilla Pilati, Julien Calderaro, Paulette Bioulac-Sage, Christophe Laurent, Alexis Laurent, Daniel Cherqui, Charles Balabaud, Jessica Zucman-Rossi. Nat Commun 2013
382
30

Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma.
Xunjun Yang, Xiuchan Guo, Yao Chen, Guorong Chen, Yin Ma, Kate Huang, Yuning Zhang, Qiongya Zhao, Cheryl A Winkler, Ping An,[...]. Oncotarget 2016
21
30


Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma.
Glynis A Scott, Todd S Laughlin, Paul G Rothberg. Mod Pathol 2014
71
30

TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung Cancer.
Rongrong Wei, Lan Cao, Hengying Pu, Hongwei Wang, Yonglan Zheng, Xiaomin Niu, Xiaoling Weng, Hong Zhang, Murray Favus, Lanjun Zhang,[...]. Clin Cancer Res 2015
34
30

Clinical and molecular features of Hürthle cell carcinoma of the thyroid.
Ana-Maria Chindris, John D Casler, Victor J Bernet, Michael Rivera, Colleen Thomas, Jennifer M Kachergus, Brian M Necela, Ian D Hay, Sydney A Westphal, Clive S Grant,[...]. J Clin Endocrinol Metab 2015
55
23

Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs).
Nathália C Campanella, Ricardo Celestino, Ana Pestana, Cristovam Scapulatempo-Neto, Antonio Talvane de Oliveira, Maria José Brito, António Gouveia, José Manuel Lopes, Denise Peixoto Guimarães, Paula Soares,[...]. Eur J Hum Genet 2015
21
23

TERT promoter mutations predict worse survival in laryngeal cancer patients.
Yiping Qu, Siwen Dang, Kexia Wu, Yuan Shao, Qi Yang, Meiju Ji, Bingyin Shi, Peng Hou. Int J Cancer 2014
33
23

Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer.
Ismail Hosen, P Sivaramakrishna Rachakonda, Barbara Heidenreich, Petra J de Verdier, Charlotta Ryk, Gunnar Steineck, Kari Hemminki, Rajiv Kumar. Int J Cancer 2015
60
23

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.
Christian Koelsche, Felix Sahm, David Capper, David Reuss, Dominik Sturm, David T W Jones, Marcel Kool, Paul A Northcott, Benedikt Wiestler, Katja Böhmer,[...]. Acta Neuropathol 2013
191
23

Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.
Pedro Castelo-Branco, Sanaa Choufani, Stephen Mack, Denis Gallagher, Cindy Zhang, Tatiana Lipman, Nataliya Zhukova, Erin J Walker, Dianna Martin, Diana Merino,[...]. Lancet Oncol 2013
156
23

TERT promoter mutations in periocular carcinomas: implications of ultraviolet light in pathogenesis.
Shih-Yao Lin, Shu-Lang Liao, Jin-Bon Hong, Chia-Yu Chu, Yi-Shuan Sheen, Jie-Yang Jhuang, Jia-Huei Tsai, Jau-Yu Liau. Br J Ophthalmol 2016
6
50

Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis.
Sabine Spiegl-Kreinecker, Daniela Lötsch, Bahil Ghanim, Christine Pirker, Thomas Mohr, Magdalena Laaber, Serge Weis, Alfred Olschowski, Gerald Webersinke, Josef Pichler,[...]. Neuro Oncol 2015
71
23

Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation.
Hsien-Neng Huang, Ying-Cheng Chiang, Wen-Fang Cheng, Chi-An Chen, Ming-Chieh Lin, Kuan-Ting Kuo. Mod Pathol 2015
18
23

TERT Promoter Mutations and Tumor Persistence/Recurrence in Papillary Thyroid Cancer.
Jae Kyung Myung, Byung Kuk Kwak, Jung Ah Lim, Myung-Chul Lee, Min Joo Kim. Cancer Res Treat 2016
12
25

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.
P Sivaramakrishna Rachakonda, Ismail Hosen, Petra J de Verdier, Mahdi Fallah, Barbara Heidenreich, Charlotta Ryk, N Peter Wiklund, Gunnar Steineck, Dirk Schadendorf, Kari Hemminki,[...]. Proc Natl Acad Sci U S A 2013
217
23

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, Rileen Sinha, Jeffrey A Knauf, Ronak H Shah, Snjezana Dogan, Julio C Ricarte-Filho, Gnana P Krishnamoorthy, Bin Xu,[...]. J Clin Invest 2016
478
23

TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas.
Ke Gao, Gang Li, Yiping Qu, Maode Wang, Bo Cui, Meiju Ji, Bingyin Shi, Peng Hou. Oncotarget 2016
41
23

Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
Xiaoli Liu, Justin Bishop, Yuan Shan, Sara Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K El-Naggar, Mingzhao Xing. Endocr Relat Cancer 2013
370
23

TERT promoter mutations in primary and secondary glioblastomas.
Naosuke Nonoguchi, Takashi Ohta, Ji-Eun Oh, Young-Ho Kim, Paul Kleihues, Hiroko Ohgaki. Acta Neuropathol 2013
150
23

TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations.
M Labussière, A L Di Stefano, V Gleize, B Boisselier, M Giry, S Mangesius, A Bruno, R Paterra, Y Marie, A Rahimian,[...]. Br J Cancer 2014
106
23

High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.
Stéphane Goutagny, Jean C Nault, Maxime Mallet, Dominique Henin, Jessica Z Rossi, Michel Kalamarides. Brain Pathol 2014
151
23

Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.
Josh Lewis Stern, Dan Theodorescu, Bert Vogelstein, Nickolas Papadopoulos, Thomas R Cech. Genes Dev 2015
108
23

Telomerase reverse transcriptase gene promoter mutations help discern the origin of urogenital tumors: a genomic and molecular study.
Song Wu, Peide Huang, Chong Li, Yi Huang, Xianxin Li, Yongqiang Wang, Chao Chen, Zhaojie Lv, Aifa Tang, Xiaojuan Sun,[...]. Eur Urol 2014
66
23

TERT promoter mutations and telomere length in adult malignant gliomas and recurrences.
Barbara Heidenreich, P Sivaramakrishna Rachakonda, Ismail Hosen, Florian Volz, Kari Hemminki, Astrid Weyerbrock, Rajiv Kumar. Oncotarget 2015
56
23

The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors.
Tiantian Liu, Taylor C Brown, C Christofer Juhlin, Adam Andreasson, Na Wang, Martin Bäckdahl, James M Healy, Manju L Prasad, Reju Korah, Tobias Carling,[...]. Endocr Relat Cancer 2014
54
23


Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT.
Matthias S Dettmer, Anja Schmitt, Hans Steinert, David Capper, Holger Moch, Paul Komminoth, Aurel Perren. Endocr Relat Cancer 2015
44
23

Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
Anna E Koopmans, Kimberley Ober, Hendrikus J Dubbink, Dion Paridaens, Nicole C Naus, Stephan Belunek, Bart Krist, Edward Post, Ellen C Zwarthoff, Annelies de Klein,[...]. Invest Ophthalmol Vis Sci 2014
44
23

TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.
Klaus G Griewank, Rajmohan Murali, Bastian Schilling, Tobias Schimming, Inga Möller, Iris Moll, Marion Schwamborn, Antje Sucker, Lisa Zimmer, Dirk Schadendorf,[...]. PLoS One 2013
60
23

Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer.
Xiaoguang Shi, Rengyun Liu, Shen Qu, Guangwu Zhu, Justin Bishop, Xiaoli Liu, Hui Sun, Zhongyan Shan, Enhua Wang, Yahong Luo,[...]. J Clin Endocrinol Metab 2015
58
23

TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomas.
Hideyuki Arita, Yoshitaka Narita, Hirokazu Takami, Shintaro Fukushima, Yuko Matsushita, Akihiko Yoshida, Yasuji Miyakita, Makoto Ohno, Soichiro Shibui, Koichi Ichimura. Acta Neuropathol 2013
48
23

Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.
Ren-Chin Wu, Ayse Ayhan, Daichi Maeda, Kyu-Rae Kim, Blaise A Clarke, Patricia Shaw, Michael Herman Chui, Barry Rosen, Ie-Ming Shih, Tian-Li Wang. J Pathol 2014
63
23

Heterogeneity of TERT promoter mutations status in squamous cell carcinomas of different anatomical sites.
Katherine A Cheng, Boaz Kurtis, Sabina Babayeva, Jian Zhuge, Irlna Tantchou, Dongming Cai, Rocco J Lafaro, John T Fallon, Minghao Zhong. Ann Diagn Pathol 2015
24
23

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, Rui Batista, Joana Peixoto, Catarina Tavares, Ricardo Celestino, Ana Almeida, Catarina Salgado, Catarina Eloy,[...]. J Clin Endocrinol Metab 2014
313
23


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.